while all of the drugs work on cgrp, they don�t all work the same way. three of them target the cgrp molecule itself. aimovig goes after cgrp's receptor in the brain. .
biohaven: "rimegepant pivotal phase 3 trial results -- conference call." .
-
.ai-based software may help predict risk of dementia
.
yet these drugs are not a "home run," says elizabeth loder, md, a professor of neurology at harvard medical school and chief of the division of headache at brigham & women's hospital.